Psyence Biomedical (PBM) said late Friday it has completed its private placement for gross proceeds of $2 million.
The company offered 1 million common shares or pre-funded warrants, series A warrants to purchase up to 1 million shares, and short-term series B warrants to purchase up to 1 million shares at a purchase price of $2 per share or per pre-funded warrant and accompanying series A and B warrants.
The warrants have an exercise price of $2 per share and are exercisable immediately upon issuance.
Proceeds from the offering are expected to be used for general corporate purposes, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments